2009 年 H1N1 流感大流行期间因抗病毒药物不良反应而就诊于急诊科的情况。
Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic.
机构信息
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA.
出版信息
Public Health Rep. 2011 May-Jun;126(3):312-7. doi: 10.1177/003335491112600303.
Abstract
The 2009 pandemic influenza A (H1N1) outbreak was associated with an increased use of antiviral agents and highlighted the role of population-based monitoring for related adverse drug events (ADEs). An ongoing, nationally representative emergency department-based surveillance system was used to identify and characterize ADEs during the pandemic. Active surveillance for ADEs successfully provided timely, population-based data during the pandemic. Increases in antiviral ADEs paralleled increases in prescribing. Type and severity of ADEs were similar across all seasons.
摘要
2009 年的甲型 H1N1 流感大流行与抗病毒药物的使用增加有关，凸显了基于人群的监测在相关药物不良事件（ADE）中的作用。正在进行的全国代表性的基于急诊的监测系统被用于识别和描述大流行期间的 ADE。主动监测 ADE 在大流行期间成功提供了及时的、基于人群的数据。抗病毒 ADE 的增加与处方的增加平行。所有季节的 ADE 的类型和严重程度相似。
相似文献
1
Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic.
Public Health Rep. 2011 May-Jun;126(3):312-7. doi: 10.1177/003335491112600303.
2
National surveillance of emergency department visits for outpatient adverse drug events.
JAMA. 2006 Oct 18;296(15):1858-66. doi: 10.1001/jama.296.15.1858.
3
US Emergency Department Visits for Adverse Drug Events From Antibiotics in Children, 2011-2015.
J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):384-391. doi: 10.1093/jpids/piy066.
4
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.
Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.
5
Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.
PLoS One. 2012;7(4):e36120. doi: 10.1371/journal.pone.0036120. Epub 2012 Apr 24.
6
Epidemiological characteristics of novel influenza A (H1N1) in antiviral drug users in Korea.
PLoS One. 2012;7(10):e47634. doi: 10.1371/journal.pone.0047634. Epub 2012 Oct 17.
7
Planning for a pandemic: a view from the accident and emergency department.
Br J Hosp Med (Lond). 2010 Feb;71(2):64-5. doi: 10.12968/hmed.2010.71.2.46475.
8
Update: influenza activity - United States, August 30-October 31, 2009.
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1236-41.
9
Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
BMC Infect Dis. 2012 Apr 20;12:97. doi: 10.1186/1471-2334-12-97.
10
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5.
引用本文的文献
1
Drug-Related Hypersensitivity Reactions Leading to Emergency Department: Original Data and Systematic Review.
J Clin Med. 2022 May 16;11(10):2811. doi: 10.3390/jcm11102811.
2
Household medication safety practices during the COVID-19 pandemic: a descriptive qualitative study protocol.
BMJ Open. 2020 Nov 24;10(11):e044441. doi: 10.1136/bmjopen-2020-044441.
3
"The COVID-19 Pandemic and its Effect on Mental Health in USA - A Review with Some Coping Strategies".
Psychiatr Q. 2020 Dec;91(4):1135-1145. doi: 10.1007/s11126-020-09836-0.
4
Worse than the Disease? The Rash of .
Kans J Med. 2018 May 18;11(2):1-6. eCollection 2018 May.
5
Cough and cold medication adverse events after market withdrawal and labeling revision.
Pediatrics. 2013 Dec;132(6):1047-54. doi: 10.1542/peds.2013-2236. Epub 2013 Nov 11.
6
Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011.
Acad Emerg Med. 2013 Aug;20(8):786-94. doi: 10.1111/acem.12175.
7
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.
Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.
本文引用的文献
1
Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.
MMWR Morb Mortal Wkly Rep. 2010 Apr 16;59(14):423-30.
2
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106.
3
Update: influenza activity - United States, August 30-October 31, 2009.
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1236-41.
4
Update: influenza activity--United States, April-August 2009.
MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):1009-12.
5
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.
Ann Intern Med. 2009 Oct 6;151(7):464-73. doi: 10.7326/0003-4819-151-7-200910060-00143. Epub 2009 Aug 3.
6
Emergence of a novel swine-origin influenza A (H1N1) virus in humans.
N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7.
7
Neuraminidase inhibitors for preventing and treating influenza in children.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD002744. doi: 10.1002/14651858.CD002744.pub2.
8
National surveillance of emergency department visits for outpatient adverse drug events.
JAMA. 2006 Oct 18;296(15):1858-66. doi: 10.1001/jama.296.15.1858.
9
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.
Drug Saf. 2005;28(1):19-34. doi: 10.2165/00002018-200528010-00002.
Zotero 插件